Skip to main content

Table 1 Baseline demographic data for women diagnosed with endometriosis treated with either simvastatin (simvastatin group) or placebo (control group)

From: Effect of simvastatin on monocyte chemoattractant protein-1 expression in endometriosis patients: a randomized controlled trial

Characteristics

Control group (N = 20)

Simvastatin group (N = 20)

P value

Age, mean ± SD (years)

31.05 ± 5.21

30.7± 5.07

0.83

BMI, mean ± SD (kg/m2)

20.91 ± 4.24

20.44 ± 3.43

0.71

Parity, N(%)

0

20 (100%)

0 (0%)

17 (88.24%)

3 (11.76%)

0.23

1

Duration of menstruation, mean ± SD (days)

4.4 ± 1.46

4.8 ± 1.11

0.36

Interval of menstruation, mean ± SD (days)

29.55 ± 1.73

28.8 ± 2.91

0.33

Infertility, N(%)

Yes

10 (50%)

10 (50%)

7 (47%)

13 (53%)

0.52

No

Stage of endometriosis, N(%)

III

7 (35%)

13 (65%)

7 (35.5%)

13 (65%)

1.00

IV

  1. BMI body mass index